AbbVie Inc. (ABBV)
NYSE: ABBV · IEX Real-Time Price · USD
165.65
-0.77 (-0.46%)
May 20, 2024, 10:33 AM EDT - Market open
AbbVie Employees
AbbVie had 50,000 employees on January 31, 2024. The number of employees did not change compared to the previous year.
Employees
50,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,088,060
Profits / Employee
$119,860
Market Cap
292.48B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ABBV News
- 3 days ago - AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week® - PRNewsWire
- 6 days ago - Alzamend Neuro Announces Initial Closing of Private Placement - Business Wire
- 7 days ago - AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders - PRNewsWire
- 8 days ago - LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP - Business Wire
- 11 days ago - Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million - Business Wire
- 14 days ago - AbbVie to Present at the Bank of America Securities Healthcare Conference - PRNewsWire
- 19 days ago - Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors - CNBC
- 19 days ago - FTC challenges ‘bogus' patents on Ozempic, other drugs that ‘block competition' - Market Watch